1. Home
  2. EH vs ENGN Comparison

EH vs ENGN Comparison

Compare EH & ENGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo EHang Holdings Limited ADS

EH

EHang Holdings Limited ADS

HOLD

Current Price

$11.00

Market Cap

745.8M

Sector

Industrials

ML Signal

HOLD

Logo enGene Holdings Inc.

ENGN

enGene Holdings Inc.

HOLD

Current Price

$7.34

Market Cap

647.1M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
EH
ENGN
Founded
2014
1999
Country
China
Canada
Employees
N/A
82
Industry
Military/Government/Technical
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
745.8M
647.1M
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
EH
ENGN
Price
$11.00
$7.34
Analyst Decision
Strong Buy
Buy
Analyst Count
4
5
Target Price
$21.85
$21.00
AVG Volume (30 Days)
641.5K
486.6K
Earning Date
05-26-2026
03-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$33.23
N/A
Revenue Next Year
$73.83
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.06
$2.66
52 Week High
$20.44
$12.25

Technical Indicators

Market Signals
Indicator
EH
ENGN
Relative Strength Index (RSI) 51.81 47.92
Support Level $9.06 $6.04
Resistance Level $12.80 $8.14
Average True Range (ATR) 0.52 0.53
MACD 0.16 0.15
Stochastic Oscillator 84.65 79.88

Price Performance

Historical Comparison
EH
ENGN

About EH EHang Holdings Limited ADS

EHang Holdings Ltd is an urban air mobility (UAM) technology platform company. It focuses on making safe, autonomous, eco-friendly air mobility accessible to everyone. EHang provides customers in various industries with unmanned aerial vehicle (UAV) systems and solutions: air mobility (including passenger transportation and logistics), smart city management, and aerial media solutions. EHang's EH216-S has received a production certificate and standard airworthiness certificate for passenger-carrying pilotless eVTOL aircraft issued by the Civil Aviation Administration of China. The group continues to explore the boundaries of the sky to make flying technologies benefit life in smart cities.

About ENGN enGene Holdings Inc.

enGene Holdings Inc is a clinical-stage biotechnology company mainstreaming genetic medicine through the delivery of therapeutics to mucosal tissues and other organs, with the goal of creating new ways to address diseases with high clinical needs, beginning with non-muscle invasive bladder cancer (NMIBC). The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.

Share on Social Networks: